K2M’s NILE Alternative Fixation Spinal System receives FDA clearance

K2M received 510(k) clearance from the U.S. Food and Drug Administration to market the NILE Alternative Fixation Spinal System.

Advertisement

The system intends to provide stabilization between the spine and the rod, and to allow for reduction, translation, compression and distraction while sparing the anatomy. The system has also received the CE Mark.

 

The first surgical case using NILE in the United States was completed in March by Burt Yaszay, MD, a pediatric orthopedic surgeon, at Rady Children’s Hospital in San Diego.

 

More articles on devices:
Synergy Disc Replacement names GM Medical Pacific exclusive distributor — 5 things to know
7 key trends in the China orthopedic device market
Innovating beyond implants — DePuy Synthes launches data-collection software & patient video

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.